Enjoy complimentary customisation on priority with our Enterprise License!
The women health therapeutics market size is forecast to increase by USD 37.2 billion, at a CAGR of 6% between 2023 and 2028.
Explore in-depth regional segment analysis with market size data - historical 2018-2022 and forecasts 2024-2028 - in the full report.
Request Free Sample
The women's health therapeutics market continues to evolve, driven by the ongoing research and development of innovative solutions for various health concerns. Bone density, a critical aspect of women's health, is being addressed through both prescription medications and over-the-counter supplements, including calcium and vitamin D. The role of natural remedies, such as black cohosh and red clover, in bone health management is also gaining attention. Cardiovascular health is another significant area of focus, with lifestyle modifications, such as diet and exercise, and pharmaceutical drugs playing essential roles. Sexual dysfunction, a common concern for women, is being addressed through a range of treatments, from prescription medications to herbal remedies and digital health solutions.
Drug development is ongoing for conditions like osteoporosis, with a focus on improving treatment adherence and minimizing adverse effects. The role of nutritional therapy, including soy isoflavones and vitamin D supplements, in osteoporosis prevention and treatment is also being explored. Stress management, a crucial component of overall health, is being addressed through various means, including mobile applications, lifestyle modifications, and personalized medicine. The integration of data analytics and predictive modeling in healthcare is enabling more effective patient education and improving healthcare costs. Women's health therapeutics also encompasses the management of menopause symptoms, such as hot flashes, night sweats, mood swings, and sleep disturbances.
Healthcare professionals are working to improve patient satisfaction through better communication and the use of clinical trials to evaluate the long-term effects of various treatments. Insurance coverage and regulatory approvals continue to shape the market, with ongoing discussions surrounding the role of herbal remedies and dietary supplements in women's health. The integration of technology, such as digital health solutions and exercise programs, is also transforming the way women manage their health and improve their quality of life.
The women health therapeutics industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD billion" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.
The fertility segment is estimated to witness significant growth during the forecast period.
The Women's Health Therapeutics market in the US is experiencing significant growth due to various factors. According to the Centers for Disease Control and Prevention (CDC), approximately 12% of married women aged 15-44 years in the US experience infertility, leading to a high adoption of female infertility drugs. The US Department of Health and Human Services reports that 12-13 out of every 100 couples face infertility issues. In Canada, the Public Health Agency reports that one in six couples and four in ten women face fertility problems annually. The market is driven by an increase in infertility risk factors, including sexually transmitted diseases (STDs), endometriosis, polycystic ovary syndrome (PCOS), poor diet, age, and diabetes.
Infertility drugs, such as prescription medications, are widely used to address these issues. However, there is a growing trend towards alternative therapies, including nutritional therapy, herbal remedies, and lifestyle modifications. Digital health technologies, such as mobile applications and data analytics, are also gaining popularity in the market. These technologies enable personalized medicine, treatment adherence, and patient education, leading to improved patient satisfaction and healthcare costs. Regulatory approvals for bioidentical hormones and over-the-counter medications have further boosted market growth. However, there are concerns regarding the long-term effects of some pharmaceutical drugs and herbal remedies, such as adverse effects on bone density, cardiovascular health, and mood swings.
Additionally, insurance coverage and affordability remain significant challenges for patients. Clinical trials are ongoing to explore the effectiveness and safety of various treatments, including drug development for osteoporosis prevention and treatment adherence strategies. Exercise programs, stress management, and vitamin D supplements are also gaining attention for their role in improving overall health and quality of life. Predictive modeling and patient education are essential components of menopause management, which is another significant area of focus in the market. Healthcare professionals are working to address the various symptoms of menopause, including hot flashes, night sweats, vaginal atrophy, and sexual dysfunction, through a combination of pharmaceutical drugs, herbal remedies, and lifestyle modifications.
In conclusion, the Women's Health Therapeutics market in the US is experiencing significant growth due to an increase in infertility risk factors and the adoption of various treatments, including prescription medications, digital health technologies, and alternative therapies. However, challenges such as long-term effects, insurance coverage, and affordability remain significant barriers to access and adoption. Ongoing clinical trials and research are providing valuable insights into the effectiveness and safety of various treatments, enabling healthcare professionals to develop more effective and personalized approaches to women's health.
The Fertility segment was valued at USD 26.20 billion in 2018 and showed a gradual increase during the forecast period.
North America is estimated to contribute 48% to the growth of the global market during the forecast period.Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
The women's health therapeutics market in North America is experiencing notable growth due to the rising adoption of advanced therapeutics for treating various conditions. For instance, the development of anticancer drugs is gaining traction, offering alternatives to traditional treatments like surgery for diseases such as fallopian tube cancer. Historically, chemotherapy has been the primary treatment option for this condition, often used in conjunction with surgery and radiation therapy. However, its limited efficacy and significant side effects have left a substantial gap in the market. Moreover, digital health solutions are increasingly being integrated into women's healthcare, improving patient satisfaction and access to care.
Regulatory approvals for prescription medications, such as bioidentical hormones and selective estrogen receptor modulators (SERMs), are driving market expansion. These therapies address issues like vaginal atrophy, hot flashes, and osteoporosis prevention. Nutritional therapy, including dietary supplements like vitamin D and calcium, as well as herbal remedies like black cohosh and red clover, are also gaining popularity. Lifestyle modifications, stress management, and exercise programs contribute to the market's growth. Patient education and healthcare costs are key factors influencing treatment decisions. Drug development is ongoing for various conditions, including breast and ovarian cancer risks, menopause management, and sexual dysfunction. Over-the-counter medications and personalized medicine are further expanding the market.
Data analytics and predictive modeling facilitate better patient care and treatment adherence. Pharmaceutical drugs and herbal remedies are used to address conditions like urinary tract health and mood swings. Long-term effects, such as cardiovascular health and cognitive function, are increasingly being considered. Sleep disturbances, night sweats, and insurance coverage are other factors influencing market trends. In summary, the women's health therapeutics market in North America is witnessing significant growth due to the development of novel therapeutics, increasing adoption of digital health solutions, and growing awareness of the importance of preventive measures and personalized care.
Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
The women health therapeutics market forecasting report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the women health therapeutics market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Companies are implementing various strategies, such as strategic alliances, women health therapeutics market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the industry.
Abbott Laboratories - This company specializes in women's health therapeutics, including ARACHITOL-O, a unique formulation of calcium citrate malate and vitamin D3. This combination supports bone density and overall well-being for women. The calcium citrate malate aids in calcium absorption, while vitamin D3 promotes calcium utilization in the body. This scientifically-backed approach enhances women's health and wellness.
The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
Dive into Technavio’s robust research methodology, blending expert interviews, extensive data synthesis, and validated models for unparalleled Women Health Therapeutics Market insights. See full methodology.
|
Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
180 |
|
Base year |
2023 |
|
Historic period |
2018-2022 |
|
Forecast period |
2024-2028 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 6% |
|
Market growth 2024-2028 |
USD 37.2 billion |
|
Market structure |
Fragmented |
|
YoY growth 2023-2024(%) |
5.6 |
|
Key countries |
US, Germany, UK, France, China, Canada, Japan, Mexico, South Korea, and Brazil |
|
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
We can help! Our analysts can customize this women health therapeutics market research report to meet your requirements.
1 Executive Summary
2 Technavio Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Qualitative Analysis
7 Five Forces Analysis
8 Market Segmentation by Type
9 Market Segmentation by Distribution Channel
10 Market Segmentation by Therapeutics Drug
11 Market Segmentation by Age Group
12 Customer Landscape
13 Geographic Landscape
14 Drivers, Challenges, and Opportunity/Restraints
15 Competitive Landscape
16 Competitive Analysis
17 Appendix
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
Secondary sources
DATA ANALYSIS
Data Synthesis
Data Validation
REPORT WRITING
Qualitative
Quantitative
Get the report (PDF) sent to your email within minutes.
Complimentary full Excel data with your report purchase.
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
